NCT02180867 · OUTCOME

Prevalence of Circulating Tumor DNA (ctDNA)

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · Source last updated 2026-06-17

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: At diagnosis

What was measured

Descriptive analyses will be performed to summarize the prevalence of ctDNA.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: Descriptive analyses will be performed to summarize the prevalence of ctDNA.
reporting Status: NOT_POSTED
time Frame: At diagnosis
title: Prevalence of Circulating Tumor DNA (ctDNA)
type: OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice